Adaptimmune Therapeutics PLC

Sign in to save

Sign in to set an alert

Tickers: ADAPY
Headquarters: Not recorded
SEC CIK: 0001621227
Website: Not recorded

Closing prices

Too many attempts. Please wait a minute and try again.

Drugs

No drugs from this company are tracked yet.

FDA-approved applications

Too many attempts. Please wait a minute and try again.

Catalysts

No catalysts yet. Editors add each date together with its source.

Deals

No approved deals involve this company yet.

Reported fundamentals (SEC XBRL)

Too many attempts. Please wait a minute and try again.

SEC filings

SEC filings from Adaptimmune Therapeutics PLC, newest first
Form	Filed	What it covers	Document
424B3	13 Nov 2025	Form 424B3	View Form 424B3 filed 13 Nov 2025 on sec.gov (opens in a new tab)Filing index for 0001193805-25-001571 (opens in a new tab)
8-K	20 Oct 2025Event 15 Oct 2025	Current report (8-K) Notice of delisting or listing rule failure (Item 3.01) Regulation FD disclosure (Item 7.01) Financial statements and exhibits (Item 9.01)	View Current report (8-K) filed 20 Oct 2025 on sec.gov (opens in a new tab)Filing index for 0001104659-25-100618 (opens in a new tab)
8-K	26 Sep 2025Event 22 Sep 2025	Current report (8-K) Notice of delisting or listing rule failure (Item 3.01)	View Current report (8-K) filed 26 Sep 2025 on sec.gov (opens in a new tab)Filing index for 0001104659-25-093882 (opens in a new tab)
8-K	12 Sep 2025Event 11 Sep 2025	Current report (8-K) Notice of delisting or listing rule failure (Item 3.01)	View Current report (8-K) filed 12 Sep 2025 on sec.gov (opens in a new tab)Filing index for 0001104659-25-089558 (opens in a new tab)
8-K	8 Sep 2025Event 6 Sep 2025	Current report (8-K) Departure or appointment of directors or officers (Item 5.02) Financial statements and exhibits (Item 9.01)	View Current report (8-K) filed 8 Sep 2025 on sec.gov (opens in a new tab)Filing index for 0001558370-25-011925 (opens in a new tab)
4	3 Sep 2025Event 2 Sep 2025	Insider transaction report (Form 4)	View Insider transaction report (Form 4) filed 3 Sep 2025 on sec.gov (opens in a new tab)Filing index for 0001104659-25-087085 (opens in a new tab)
4	29 Aug 2025Event 28 Aug 2025	Insider transaction report (Form 4)	View Insider transaction report (Form 4) filed 29 Aug 2025 on sec.gov (opens in a new tab)Filing index for 0001104659-25-085820 (opens in a new tab)
8-K	29 Aug 2025	Current report (8-K) Departure or appointment of directors or officers (Item 5.02) Financial statements and exhibits (Item 9.01)	View Current report (8-K) filed 29 Aug 2025 on sec.gov (opens in a new tab)Filing index for 0001558370-25-011820 (opens in a new tab)
4	19 Aug 2025Event 15 Aug 2025	Insider transaction report (Form 4)	View Insider transaction report (Form 4) filed 19 Aug 2025 on sec.gov (opens in a new tab)Filing index for 0000950170-25-110254 (opens in a new tab)
8-K	15 Aug 2025	Current report (8-K) Departure or appointment of directors or officers (Item 5.02) Financial statements and exhibits (Item 9.01)	View Current report (8-K) filed 15 Aug 2025 on sec.gov (opens in a new tab)Filing index for 0001558370-25-011616 (opens in a new tab)

Source: SEC EDGAR. Each row links to the filing on sec.gov.

Related news

No recent headlines mention this company.

Insider transactions

Last 90 days of Form 4 filings, from 3 Aug 2026 (US Eastern dates).

Buys code P: None in this period
Sells code S: None in this period
Other all other codes: None in this period

Last transaction: 2 Sep 2025

Insider filings are public records and are not a recommendation. Source: SEC EDGAR.

Sources

Editor source (opens in a new tab) Licence: editorial. Entered by an editor, not fetched automatically
SEC EDGAR submissions (opens in a new tab) Licence: public-domain. Fetched 25 Oct 2026

Nothing on this page is investment advice.